Answers are grounded in this paper and cite their sources.
BACKGROUND: Mood and anxiety disorders are common in cancer survivors, and are associated with worse outcomes; however, systematic identification of high-risk patients remains limited, despite screening and intervention guidelines. A systematic review and meta-analysis were conducted to identify risk factors for mood and anxiety disorders, including diagnoses and clinically significant symptoms, in adult cancer survivors. METHODS: PubMed, Web of Science, Embase, PsycINFO, and Cochrane Central Register of Controlled Trials were searched for cohort and case-control studies published from January 2000 to November 2024 that evaluated cancer-related, sociodemographic, lifestyle, and psychosocial risk factors in adults with breast, lung, colorectal, prostate, stomach, liver, or pancreatic cancer. Random-effects models with robust variance estimation pooled relative risks (RRs) and 95% confidence intervals (CIs) for factors assessed in ≥5 studies. RESULTS: Fifty of the 53 eligible studies were included in the meta-analysis. Consistent risk factors included high tumor stage (vs. low; n = 28; RR, 1.55; 95% CI, 1.21-1.97), more physical comorbidities (vs. fewer; n = 36; RR, 1.57; 95% CI, 1.34-1.84), prior psychiatric history (high vs. low burden; n = 13; RR, 4.85; 95% CI, 2.77-8.50), female sex (vs. male; n = 19; RR, 1.52; 95% CI, 1.32-1.75), underweight body mass index (vs. normal; n = 6; RR, 1.93; 95% CI, 1.55-2.44), unmarried status (vs. married; n = 25; RR, 1.35; 95% CI, 1.14-1.58), and current smoking (vs. never; n = 12; RR, 1.27; 95% CI, 1.12-1.46). Suggestive associations, although less consistent in sensitivity analyses, were observed for high tumor grade, more extensive surgery, low income, low education, and low social support. CONCLUSIONS: Several clinical and social factors were associated with increased risk of mood and anxiety outcomes in adult cancer survivors. These findings may support risk-based psychiatric screening and early intervention in resource-limited oncology settings.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: